Arbutus Biopharma
$2.229876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$2.22
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.04 (-1.77%) Today
$0.00 (0.00%) As of 8:00 PM EST after-hours
Why Robinhood?
You can buy or sell ABUS and other stocks, options, ETFs, and crypto commission-free!
About ABUS
Arbutus Biopharma Corp. engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection. The company is headquartered in Burnaby, Canada.
Employees
80
Headquarters
Burnaby, British Columbia
Founded
2005
Market Cap
113.70M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
805.29K
High Today
$2.43
Low Today
$2.15
Open Price
$2.22
Volume
379.51K
52 Week High
$4.78
52 Week Low
$0.8214
Collections
ABUS Earnings
-$0.73
-$0.59
-$0.44
-$0.30
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Estimated
—
Actual
Expected Mar 5, Pre-Market